Dr. Leng Han joined Indiana University School of Medicine as David Brown Chair Professor of Genomic Medicine in June 2023, with the dual appointment at both Brown Center for Immunotherapy and Department of Biostatistics and Health Data Science. He was recruited from Texas A&M University, Institute of Biosciences & Technology where he was an Associate Professor and CPRIT scholar. Before join TAMU, he is an Assistant Professor at The University of Texas Health Science Center at Houston. Dr. Han obtained his PhD from Chinese Academy of Sciences and did postdoc training at Stanford University and MD Anderson Cancer Center.
Dr. Han’s lab focused on harnessing big data for precision medicine. In the past several years, his labs contributed to RNA-targeted therapy, target therapy and immunotherapy, and published several papers in high profile journals, including Cancer Cell, Nature Metabolism, Nature Immunology, Cell Metabolism, Nature Communications, The Innovation, Cell Systems, Cell Reports, Nucleic Acids Research, Genome Medicine, Journal of the National Cancer Institute. He has been invited to contribute review, commentary and spotlight by multiple journals, including Nature Reviews Clinical Oncology, Nature Biotechnology, Cell Reports Medicine, Trends in Genetics, Trends in Cancer, Trends in Molecular Medicine, Genome Medicine, and Oncogene. To date, he has published more than 160 peer-reviewed papers, with a total of over 23,000 citations (Google scholar, H-index = 63). He also served as editorial member for several prestigious journals, such as Genome Biology, and Genome Medicine.